Real-time enrollment status for this ovarian cancer clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 12:23 PM UTC
| NCT Number | NCT05128825 |
| Recruiting Status | Recruiting |
| Condition | Ovarian Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 170 participants |
| Active Locations | 39 sites in the US |
| Sponsor | K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc |
| Last Updated on CT.gov | February 11, 2026 (2 weeks ago) |
As of March 2, 2026: Clinical trial NCT05128825 is currently recruiting participants. This clinical trial study for ovarian cancer is actively seeking new participants at 39 locations across the United States. The study is sponsored by K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05128825 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 39 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05128825 was last updated 2 weeks ago (February 11, 2026). HelloStudys verifies this status automatically.